The mRNA-1273 vaccine is being developed to prevent COVID-19. The purpose of this study is to test Moderna’s vaccine candidate to see if it can prevent illness if people are exposed to the SARS-CoV-2 virus in their everyday lives. The mRNA-1273 vaccine is not made from the SARS-CoV-2 virus. It is made from messenger ribonucleic acid (mRNA), a genetic code that tells cells how to make protein, which helps the body’s immune system make antibodies to fight the virus. The vaccine cannot cause infection or make someone sick with COVID-19.
Visit ClinicalTrials.gov - NCT04470427 for additional details about the Moderna COVID-19 vaccine clinical study.
BNT162b2 is an investigational mRNA vaccine being developed by Pfizer and BioNTech to help prevent COVID-19, the disease caused by the SARS-CoV-2 virus. The purpose of the study is to test how well the investigational vaccine works at preventing COVID-19 disease and evaluate whether it is safe for adults and adolescents. BNT162b2 contains a small part of the genetic code for the SARS-CoV-2 spike protein. BNT162b2 does not contain any live virus. It cannot give you SARS-CoV-2 infection, nor will you get COVID-19.
Visit ClinicalTrials.gov - NCT04368728 for additional details about the Pfizer and BioNTech COVID-19 vaccine clinical study.
This infographic provides information on mRNA vaccines safety and adverse events (side effects).
This infographic provides an overview of how mRNA vaccines work and the importance of receiving 2 doses.
This infographic provides an overview of the benefits of receiving 2 doses of the EUA mRNA vaccines. It also provides information on priority groups included in the vaccine trials, underscoring safety and efficacy for these groups.
This infographic highlights the reasons why continued research for other COVID-19 vaccines is needed. It emphasizes the need to continue wearing masks in the absence of data demonstrating protection against infection.